ABT Abbott Laboratories

Issuer:

Abbott Laboratories

Principal Amount:

$750,000,000

Ratings:

A2/A+ (Moody’s Investor Services/Standard & Poor’s Ratings Service)

Coupon:

2.000%

Maturity:

March 15, 2020

Price to Public:

99.810% plus accrued interest, if any, from March 10, 2015

Yield to maturity:

2.040%

Benchmark Treasury:

1.375% due February 29, 2020

Spread to Benchmark Treasury:

+48 bps

Treasury Price and Yield:

99-033/4 / 1.560%

Coupon Dates:

Semiannually on March 15 and September 15

First Coupon:

September 15, 2015

Settlement Date:

March 10, 2015

Redemption Provisions:

Abbott may redeem the notes, at any time in whole or from time to time in part, at a redemption price equal to the greater of (1) 100% of the principal amount of the notes being redeemed, or (2) the sum of the present values of the remaining scheduled payments of principal and interest on the notes being redeemed, discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the Treasury Yield plus 10 basis points, plus, in either case, accrued and unpaid interest, if any, to the redemption date on the principal amount of the notes being redeemed.

CUSIP:

002824 AZ3

Joint Bookrunning Managers:

Barclays Capital Inc.

Merrill Lynch, Pierce, Fenner & Smith

Incorporated

J.P. Morgan Securities LLC

Morgan Stanley & Co. LLC

BNP Paribas Securities Corp.

Senior Co-Manager:

Deutsche Bank Securities Inc.

SG Americas Securities, LLC

Mitsubishi UFJ Securities (USA), Inc.

RBS Securities Inc.

Co-Managers:

HSBC Securities (USA) Inc.

Standard Chartered Bank

Santander Investment Securities Inc.

Goldman, Sachs & Co.

The Williams Capital Group, L.P.

BBVA Securities Inc.

ING Financial Markets LLC

Mizuho Securities USA Inc.

RBC Capital Markets, LLC

U.S. Bancorp Investments, Inc.

Banca IMI S.p.A.

Issuer:

Abbott Laboratories

Principal Amount:

$750,000,000

Ratings:

A2/A+ (Moody’s Investor Services/Standard & Poor’s Ratings Service)

Coupon:

2.550%

Maturity:

March 15, 2022

Price to Public:

99.834% plus accrued interest, if any, from March 10, 2015

Yield to maturity:

2.576%

Benchmark Treasury:

1.750% due February 28, 2022

Spread to Benchmark Treasury:

+68 bps

Treasury Price and Yield:

99.01+ / 1.896%

Coupon Dates:

Semiannually on March 15 and September 15

First Coupon:

September 15, 2015

Settlement Date:

March 10, 2015

Redemption Provisions:

Abbott may redeem the notes, at any time in whole or from time to time in part, at a redemption price equal to the greater of (1) 100% of the principal amount of the notes being redeemed, or (2) the sum of the present values of the remaining scheduled payments of principal and interest on the notes being redeemed, discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the Treasury Yield plus 12.5 basis points, plus, in either case, accrued and unpaid interest, if any, to the redemption date on the principal amount of the notes being redeemed.

CUSIP:

002824 BA7

Joint Bookrunning Managers:

Barclays Capital Inc.

Merrill Lynch, Pierce, Fenner & Smith

Incorporated

J.P. Morgan Securities LLC

Morgan Stanley & Co. LLC

SG Americas Securities, LLC

Senior Co-Manager:

BNP Paribas Securities Corp.

Deutsche Bank Securities Inc.

Mitsubishi UFJ Securities (USA), Inc.

RBS Securities Inc.

Co-Managers:

HSBC Securities (USA) Inc.

Standard Chartered Bank

Santander Investment Securities Inc.

Goldman, Sachs & Co.

The Williams Capital Group, L.P.

BBVA Securities Inc.

ING Financial Markets LLC

Mizuho Securities USA Inc.

RBC Capital Markets, LLC

U.S. Bancorp Investments, Inc.

Banca IMI S.p.A.

Issuer:

Abbott Laboratories

Principal Amount:

$1,000,000,000

Ratings:

A2/A+ (Moody’s Investor Services/Standard & Poor’s Ratings Service)

Coupon:

2.950%

Maturity:

March 15, 2025

Price to Public:

99.793% plus accrued interest, if any, from March 10, 2015

Yield to maturity:

2.974%

Benchmark Treasury:

2.000% due February 15, 2025

Spread to Benchmark Treasury:

+88 bps

Treasury Price and Yield:

99-05 / 2.094%

Coupon Dates:

Semiannually on March 15 and September 15

First Coupon:

September 15, 2015

Settlement Date:

March 10, 2015

Redemption Provisions:

Abbott may redeem the notes, at any time in whole or from time to time in part, at a redemption price equal to the greater of (1) 100% of the principal amount of the notes being redeemed, or (2) the sum of the present values of the remaining scheduled payments of principal and interest on the notes being redeemed, discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate equal to the Treasury Yield plus 15 basis points, plus, in either case, accrued and unpaid interest, if any, to the redemption date on the principal amount of the notes being redeemed.

Notwithstanding the foregoing, if the notes are redeemed on or after December 15, 2024, the redemption price will be 100% of the principal amount of the notes to be redeemed plus accrued and unpaid

interest, if any, to the redemption date on the principal amount of the notes being redeemed.

CUSIP:

002824 BB5

Joint Bookrunning Managers:

Barclays Capital Inc.

Merrill Lynch, Pierce, Fenner & Smith

Incorporated

J.P. Morgan Securities LLC

Morgan Stanley & Co. LLC

Deutsche Bank Securities Inc.

Senior Co-Manager:

BNP Paribas Securities Corp.

SG Americas Securities, LLC

Mitsubishi UFJ Securities (USA), Inc.

RBS Securities Inc.

Co-Managers:

HSBC Securities (USA) Inc.

Standard Chartered Bank

Santander Investment Securities Inc.

Goldman, Sachs & Co.

The Williams Capital Group, L.P.

BBVA Securities Inc.

ING Financial Markets LLC

Mizuho Securities USA Inc.

RBC Capital Markets, LLC

U.S. Bancorp Investments, Inc.

Banca IMI S.p.A.